Online Database of Chemicals from Around the World

Fexofenadine hydrochloride
[CAS# 153439-40-8]

Top Active Suppliers
Chizhou Dongsheng Pharmaceutical Co., Ltd. China Inquire  
+86 (576) 8429-2571
ksz@dspharmchem.com
Chemical manufacturer since 1995
chemBlink premium supplier since 2011
Identification
Classification Biochemical >> Inhibitor >> Neuronal signaling >> Histamine receptor inhibitor
Name Fexofenadine hydrochloride
Synonyms 2-[4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoic acid hydrochloride; Allegra
Molecular Structure CAS # 153439-40-8 (138452-21-8), Fexofenadine hydrochloride, 2-[4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoic acid hydrochloride, Allegra
Molecular Formula C32H39NO4.HCl
Molecular Weight 538.13
CAS Registry Number 153439-40-8 (138452-21-8)
EC Number 604-906-2
SMILES CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl
Properties
Solubility 50 mM (DMSO)
Safety Data
Hazard Symbols symbol symbol   GHS07;GHS08 Danger    Details
Hazard Statements H302-H312-H315-H317-H319-H335-H360-H361d    Details
Precautionary Statements P203-P261-P264-P264+P265-P270-P271-P272-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P317-P318-P319-P321-P330-P332+P317-P333+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Reproductive toxicityRepr.1BH360
Skin sensitizationSkin Sens.1H317
Eye irritationEye Irrit.2H319
Acute toxicityAcute Tox.2H312
Skin irritationSkin Irrit.2H315
SDS Available
up Discovory and Applicatios
Fexofenadine hydrochloride is a second-generation antihistamine commonly used to alleviate symptoms associated with allergic rhinitis, such as sneezing, runny nose, and itchy eyes. It also treats chronic idiopathic urticaria, a skin condition characterized by hives and itching. Fexofenadine hydrochloride is a derivative of terfenadine, an older antihistamine, but with significant improvements in safety and effectiveness. It was discovered as part of an effort to create antihistamines that do not cause sedation, a common side effect in first-generation compounds.

Fexofenadine was developed by modifying the structure of terfenadine, primarily to eliminate the risk of cardiac arrhythmias, which was a serious side effect associated with terfenadine. Researchers identified that fexofenadine, a carboxylated form of the parent compound, retained the desired antihistamine effects without being metabolized into potentially harmful byproducts. This led to its approval by regulatory agencies and its commercialization as a safer alternative.

The mechanism of action of fexofenadine hydrochloride involves blocking the H1 receptors for histamine in the body. Histamine is released during allergic reactions, causing inflammation and symptoms such as itching and swelling. By selectively inhibiting H1 receptors, fexofenadine prevents histamine from binding to these receptors, thereby reducing allergic symptoms. One of the key advantages of fexofenadine is its minimal penetration into the central nervous system, which reduces the risk of drowsiness, a frequent side effect seen in older antihistamines.

Fexofenadine hydrochloride is widely used in both prescription and over-the-counter formulations for allergy management. Its efficacy in treating allergic rhinitis and chronic urticaria makes it one of the most commonly recommended non-sedating antihistamines. Fexofenadine’s rapid onset of action, usually within one hour of oral administration, and its relatively long half-life allow for once or twice daily dosing, enhancing patient compliance.

The compound is also well-tolerated across different populations, including children and the elderly. Fexofenadine has minimal drug interactions and can be co-administered with various medications without significant risk of adverse effects. It is excreted primarily unchanged in the feces and urine, minimizing the strain on the liver, which makes it suitable for individuals with hepatic impairments.

Ongoing research is investigating additional applications of fexofenadine hydrochloride, particularly in managing other allergic and inflammatory conditions. Some studies have suggested its potential in addressing symptoms related to asthma, although more research is needed. Additionally, the non-sedative nature of fexofenadine makes it a candidate for combination therapies where sedative side effects must be avoided.

Fexofenadine hydrochloride remains a cornerstone in allergy treatment due to its balance of efficacy, safety, and convenience. It has become an essential tool for managing allergic conditions in a wide array of patient populations.
Market Analysis Reports
List of Reports Available for Fexofenadine hydrochloride
Related Products
Fesoterodine  (R)-Fesoterodine fumarate  rac-Fesoterodine-d14 fumarate  Festinavir  Fevipiprant  Fexaramine  Fexinidazole  (R)-Fexofenadine  Fexofenadine  Fexofenadine Acetophenone  Fexofenadine methyl ester  Fexofenadine N-Oxide  Fezolinetant  Fiacitabine  Fialuridine  Fiboflapon  Fibrinogen from human plasma  Fibrinopeptide B  Fibroblast Growth Factor  Fibroblast growth factor 2